https://www.thebodypro.com/category/hiv-treatment-as-prevention
HIV Prevention Methods

U=U (Undetectable Equals Untransmittable, i.e. HIV Treatment as Prevention)

The Latest

integrase inhibitor
News

This Week in HIV Research: The Fast-Acting Power of Integrase

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

By Barbara Jungwirth and Myles Helfand
virology
News

This Week in HIV Research: Is Viral Suppression an STI Prevention Tool?

March 5, 2020: How U=U reduces more than HIV transmission; "other" HPV strain risks post-vaccination; vitamin E for nonalcoholic steatohepatitis; HCV therapy and increased cardiovascular risk.

By Barbara Jungwirth and Myles Helfand
men on beach
News

This Week in HIV Research: Do You Believe in U=U?

Feb. 27, 2020: U=U perception vs. reality; frequency of incorrect self-reported viral load levels; how HIV transmission cluster predicts care continuum gaps; integrase inhibitor uptake and discontinuation.

By Barbara Jungwirth and Myles Helfand
three human skeleton models doing "see no evil, hear no evil, speak no evil"
News

This Week in HIV Research: Bone Concerns Aren’t Just for Older Folks

Jan. 9, 2020: Bone loss after HIV treatment initiation; aging and antiretroviral dosage; more U=U evidence for women; viral suppression and executive function.

By Barbara Jungwirth and Myles Helfand
Customer giving medical prescription to pharmacist
News Analysis

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

By Larry Buhl
Scientist holding slide with blood sample in lab
News

This Week in HIV Research: U=U Grows Ever Stronger

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.

By Barbara Jungwirth and Myles Helfand
U=U at USCA2019. Left to right: Deondre Moore, Bruce Richman, Demetre Daskalakis, Victor Claros, Yonce Jones
News Analysis

The U.S. Congress Recently Recognized "U=U." Here's How It Happened.

This inspiring moment from the U.S. Conference on AIDS illustrates how relationships can produce results for advocates.

By Aaron Anderson
woman's hand dangling keys
News

This Week in HIV Research: New Keys to the Care Continuum

Sept. 12, 2019: Better virologic outcomes at coordinated walk-in facilities offering incentives; same-day PrEP initiation at STD clinics; U=U and "low drug regimens"; adherence trends among perinatally infected adolescents.

By Barbara Jungwirth and Myles Helfand
nurse looking at medical chart
News

This Week in HIV Research: What's in a Blip?

Aug. 29, 2019: Viral load blips, low-level viremia, and eventual virologic failure; pinpointing non-adherence as a cause of HIV treatment failure; HIV care costs vary widely throughout U.S.; Kaposi sarcoma incidence in the modern HIV treatment era.

By Barbara Jungwirth and Myles Helfand
woman using facebook app on phone
Conference Coverage

Meet Young People on Their Own Terms and Don’t Judge Their Sex Lives, Experts Agree

Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.

By Barbara Jungwirth